At-Home Hemoglobin A1c Testing During COVID-19 Improved Glycemic Control
AJMC,
ABSTRACT Objectives: COVID-19 has exacerbated barriers to routine testing for chronic disease management.
ABSTRACT Objectives: COVID-19 has exacerbated barriers to routine testing for chronic disease management.
Background: A previous study reported that a median of 5.6 years of intensive versus standard glucose lowering in veterans with…
Here are what the editors at HealthDay consider to be the most important developments in Nursing for June 2019.
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for June 2019.
Here are what the editors at HealthDay consider to be the most important developments in Pathology for June 2019.
Here are what the editors at HealthDay consider to be the most important developments in Hematology
Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for June 2019.
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for June 2019.
Nei pazienti con diabete di tipo 2 il controllo intensivo della glicemia non ha aiutato a ridurre il rischio a lungo termine di…
The lack of a "legacy effect" of intensive glucose lowering at 15 years in the Veterans Affairs Diabetes Trial ( VADT …
1. In a 15-year observational cohort study of type 2 diabetics treated with intensive compared to standard glucose control…
/Maya Kruchancova, stockadobecom Phoenix/Arizona Eine strenge Blutzuckereinstellung allein kann Patienten mit Typ-2-Diabetes…
(HealthDay News) — There seems to be no evidence of a legacy effect or mortality benefit for intensive glucose control among…
HealthDay News — There seems to be no evidence of a legacy effect or mortality benefit for intensive glucose control among…
(HealthDay)—There seems to be no evidence of a legacy effect or mortality benefit for intensive glucose control among military…
(HealthDay News) -- There seems to be no evidence of a legacy effect or mortality benefit for intensive glucose control among…
Intensive glucose control was no help for reducing long-term risk of cardiovascular events, according to 15-year data from the…
Intensive glucose control was no help for reducing long-term risk of cardiovascular events, according to 15-year data from the…
A cohort of veterans with longstanding type 2 diabetes assigned to an intensive glucose-control regimen for 5 years were just…
-- There seems to be no evidence of a legacy effect or mortality benefit for intensive glucose control among military veterans…